Bigora Sian Insider Trades

Insider Trading History

Track insider trading activity for Bigora Sian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $20.6k 7,481 shares
Last Trade
Apr 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.34k 1,971 shares
$2.71
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $20.6k 7,496 shares
Last Trade
Apr 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.34k 1,986 shares
$2.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $15.2k 5,510 shares
Last Trade
Apr 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.34k 1,799 shares
$2.97
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $10.2k 3,711 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.35k 2,107 shares
$2.54
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$717 249 shares
$2.88
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $4.41k 1,604 shares
Last Trade
Jan 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$717 249 shares
$2.88
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $792k 288,000 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.6k 288,000 shares
$0.20
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $4.6M 1,672,087 shares
Last Trade
Jul 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 1,659,185 shares
$0.25
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $102k 36,937 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.2k 15,059 shares
$0.41
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $92.5k 33,626 shares
Last Trade
Apr 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.36k 3,311 shares
$0.41
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $76.9k 27,961 shares
Last Trade
Jun 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$909 404 shares
$2.25
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $60.9k 22,139 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.2k 1,675 shares
$6.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $59k 21,458 shares
Last Trade
Jan 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.46k 368 shares
$6.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $60k 21,826 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.2k 1,675 shares
$6.69
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $1.32M 480,475 shares
Last Trade
Jan 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.4M 124,397 shares
$550.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $979k 356,073 shares
Last Trade
Dec 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.62M 13,851 shares
$550.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $941k 342,227 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7M 13,850 shares
$1,130.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $1.11M 403,019 shares
Last Trade
Aug 05, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12M 7,601 shares
$1,585.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $903k 328,377 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36M 25,611 shares
$1,405.00
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Development Officer
Holding Value $833k 302,766 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384M 247,841 shares
$1,550.00
$2.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up